These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14084387)

  • 1. CURRENT THERAPEUTICS. 192. PENICILLAMINE.
    WALSHE JM
    Practitioner; 1963 Dec; 191():789-95. PubMed ID: 14084387
    [No Abstract]   [Full Text] [Related]  

  • 2. D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE.
    SCHEINBERG IH
    J Chronic Dis; 1964 Apr; 17():293-8. PubMed ID: 14141837
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE USE OF PENICILLAMINE AND N-ACETYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
    VERVEEN G; ELSKAMP DM
    Pharm Weekbl; 1964 May; 99():577-8. PubMed ID: 14146276
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE USE OF PENICILLAMINE AND N-ACTYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
    VERVEEN G; ELSKAMP DM
    Pharm Weekbl; 1964 May; 99():547-54. PubMed ID: 14146274
    [No Abstract]   [Full Text] [Related]  

  • 5. [EFFECT OF D-PENICILLAMINE ON THE EXCRETION OF MERCURY AND LEAD IN THE URINE].
    TEISINGER J; SRBOVA J
    Prac Lek; 1964 Dec; 16():433-5. PubMed ID: 14249613
    [No Abstract]   [Full Text] [Related]  

  • 6. [10 years of penicillamine].
    Werner T; Weinmann HM
    Med Klin; 1966 Nov; 61(46):1827-31. PubMed ID: 4231534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penicillamine in the light of current clinical research].
    Beritić T; Dimov
    Lijec Vjesn; 1970 Dec; 92(12):1449-53. PubMed ID: 5002621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Method and surveillance of treatment by penicillamine during hepatolenticular degeneration and in poisonings. (Apropos of 3 cases)].
    PIERI J; TRONCONI ; MOREAU ; EISINGER
    Mars Med; 1963; 100():51-7. PubMed ID: 13943419
    [No Abstract]   [Full Text] [Related]  

  • 9. [D(-)penicillamine: pharmacology and clinical uses].
    Gattoni A; De Donato MT; Catalano G; Astarita C; Bernabò R; Altucci P
    Clin Ter; 1982 Nov; 103(4):411-44. PubMed ID: 6217944
    [No Abstract]   [Full Text] [Related]  

  • 10. Penicillamine.
    Med Lett Drugs Ther; 1967 Jun; 9(13):51-2. PubMed ID: 6035365
    [No Abstract]   [Full Text] [Related]  

  • 11. COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
    Trans Am Neurol Assoc; 1963; 88():221-2. PubMed ID: 14272232
    [No Abstract]   [Full Text] [Related]  

  • 12. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.
    STERNLIEB I; SCHEINBERG IH
    JAMA; 1964 Sep; 189():748-54. PubMed ID: 14174052
    [No Abstract]   [Full Text] [Related]  

  • 13. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects and adverse effects of D-penicillamine].
    Perings E; Junge U
    Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780
    [No Abstract]   [Full Text] [Related]  

  • 15. MERCURY IN HOUSE PAINT AS A CAUSE OF ACRODYNIA. EFFECT OF THERAPY WITH N-ACETYL-D,L-PENICILLAMINE.
    HIRSCHMAN SZ; FEINGOLD M; BOYLEN G
    N Engl J Med; 1963 Oct; 269():889-93. PubMed ID: 14050987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Solution of several problems of toxicologic and legal chemistry by atomic absorption].
    Brandenberger H
    Ann Biol Clin (Paris); 1967; 25(10):1053-62. PubMed ID: 5584999
    [No Abstract]   [Full Text] [Related]  

  • 17. HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE). TWO DIFFERENT COMPONENTS.
    DENNY-BROWN D
    N Engl J Med; 1964 May; 270():1149-56. PubMed ID: 14129061
    [No Abstract]   [Full Text] [Related]  

  • 18. PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
    HARTLEY BS; WALSHE JM
    Lancet; 1963 Aug; 2(7305):434-5. PubMed ID: 14044316
    [No Abstract]   [Full Text] [Related]  

  • 19. [OCULAR MANIFESTATIONS OF CYSTINOSIS WITHIN THE FRAMEWORK OF FAMILIAL NEPHROPATHIES].
    HUDELO J
    Ann Ocul (Paris); 1964 Jan; 197():30-43. PubMed ID: 14107611
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure, properties, and function of a copper(I)-copper(II) complex of D-penicillamine: pentathallium(I) mu8-chloro-dodeca (D-penicillaminato)-octacuprate(I)hexacuprate(II) n-hydrate.
    Birker PJ; Freeman HC
    J Am Chem Soc; 1977 Oct; 99(21):6890-9. PubMed ID: 903530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.